2011
DOI: 10.1038/nprot.2011.355
|View full text |Cite
|
Sign up to set email alerts
|

Selecting protein N-terminal peptides by combined fractional diagonal chromatography

Abstract: In recent years, procedures for selecting the N-terminal peptides of proteins with analysis by mass spectrometry have been established to characterize protease-mediated cleavage and protein α-N-acetylation on a proteomic level. As a pioneering technology, N-terminal combined fractional diagonal chromatography (COFRADIC) has been used in numerous studies in which these protein modifications were investigated. Derivatization of primary amines--which can include stable isotope labeling--occurs before trypsin dige… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
183
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 161 publications
(184 citation statements)
references
References 51 publications
1
183
0
Order By: Relevance
“…[6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21] In addition to providing unbiased information about which proteins are cleaved, in some cases, these experiments locate the precise sites and quantify the rates of cleavage.…”
Section: -5mentioning
confidence: 99%
“…[6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21] In addition to providing unbiased information about which proteins are cleaved, in some cases, these experiments locate the precise sites and quantify the rates of cleavage.…”
Section: -5mentioning
confidence: 99%
“…After blocking the activity of endogenous caspases by iodoacetamide (42) (39,43). As part of the N-terminal COFRADIC protocol, differential acetylation was then used to distinguish further between the two light-labeled samples (N-hydroxysuccinimide trideutero-acetate was used for the caspase-2, -3, and -7 samples and N-hydroxysuccinimide acetate for the control sample) and to distinguish between in vitro and in vivo N-acetylation of the caspase-treated samples, the former indicative for proteolytic events (43). Recombinant human active caspase-2, -3, and -7 were purchased from R&D Systems (Minneapolis, MN) (43).…”
Section: Silac Labeling and N-terminal Cofradic Setup-silacmentioning
confidence: 99%
“…F-12K medium was supplemented with 0.3 mM L-arginine (15% of the standard concentration, at which the conversion of L-arginine to proline was not observed) using [ 12 After SILAC labeling, A549 cells were harvested and lysed as described (42). After blocking the activity of endogenous caspases by iodoacetamide (42) (39,43). As part of the N-terminal COFRADIC protocol, differential acetylation was then used to distinguish further between the two light-labeled samples (N-hydroxysuccinimide trideutero-acetate was used for the caspase-2, -3, and -7 samples and N-hydroxysuccinimide acetate for the control sample) and to distinguish between in vitro and in vivo N-acetylation of the caspase-treated samples, the former indicative for proteolytic events (43).…”
Section: Silac Labeling and N-terminal Cofradic Setup-silacmentioning
confidence: 99%
“…Free ␣-amines occur on some proteins that are never N-terminally acetylated, and can also be regenerated by signal or transit peptide removal during protein trafficking, and endo-or exoproteolysis during protein maturation and signaling. Thus, there has been considerable effort to develop unbiased proteomic methods to characterize the ␣-aminome in healthy and diseased states (3)(4)(5)(6)(7)(8).…”
mentioning
confidence: 99%